Repligen [RGEN] vs AptarGroup [ATR] Detailed Stock Comparison
Repligen
NASDAQ
Loading...
AptarGroup
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Repligen wins in 3 metrics, AptarGroup wins in 16 metrics, with 0 ties. AptarGroup appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Repligen | AptarGroup | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 511.11 | 24.30 | AptarGroup |
| Price-to-Book Ratio | 3.31 | 3.43 | Repligen |
| Debt-to-Equity Ratio | 34.44 | 43.12 | Repligen |
| PEG Ratio | 65.76 | 23.73 | AptarGroup |
| EV/EBITDA | 55.78 | 12.70 | AptarGroup |
| Profit Margin (TTM) | -2.05% | 10.84% | AptarGroup |
| Operating Margin (TTM) | 6.36% | 15.17% | AptarGroup |
| EBITDA Margin (TTM) | 6.36% | 15.17% | AptarGroup |
| Return on Equity | -1.29% | 15.26% | AptarGroup |
| Return on Assets (TTM) | -0.90% | 7.10% | AptarGroup |
| Free Cash Flow (TTM) | $142.49M | $349.22M | AptarGroup |
| Dividend Yield | N/A | 0.90% | N/A |
| 1-Year Return | -32.13% | -2.40% | AptarGroup |
| Price-to-Sales Ratio (TTM) | 9.76 | 2.57 | AptarGroup |
| Enterprise Value | $6.67B | $10.15B | AptarGroup |
| EV/Revenue Ratio | 9.89 | 2.81 | AptarGroup |
| Gross Profit Margin (TTM) | 53.65% | 37.99% | Repligen |
| Revenue per Share (TTM) | $12 | $54 | AptarGroup |
| Earnings per Share (Diluted) | $-0.25 | $5.79 | AptarGroup |
| Beta (Stock Volatility) | 1.05 | 0.57 | AptarGroup |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Repligen vs AptarGroup Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Repligen | -1.89% | -3.03% | -8.77% | -10.53% | -27.25% | -20.64% |
| AptarGroup | 0.19% | -10.60% | -12.72% | -7.20% | -1.88% | -8.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Repligen | -32.13% | -55.40% | -22.09% | 222.31% | 3,307.29% | 3,296.97% |
| AptarGroup | -2.40% | 26.48% | 18.57% | 101.07% | 235.70% | 460.39% |
Performance & Financial Health Analysis: Repligen vs AptarGroup
| Metric | RGEN | ATR |
|---|---|---|
| Market Information | ||
| Market Cap | $6.58B | $9.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,189,571 | 520,779 |
| 90 Day Avg. Volume | 868,660 | 407,540 |
| Last Close | $111.37 | $140.76 |
| 52 Week Range | $102.97 - $182.52 | $130.85 - $178.03 |
| % from 52W High | -38.98% | -20.93% |
| All-Time High | $327.32 (Sep 20, 2021) | $178.03 (Nov 11, 2024) |
| % from All-Time High | -65.98% | -20.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | 1.60% | 0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.11% |
| Operating Margin (TTM) | 0.06% | 0.15% |
| Return on Equity (TTM) | -0.01% | 0.15% |
| Debt to Equity (MRQ) | 34.44 | 43.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.34 | $41.04 |
| Cash per Share (MRQ) | $12.41 | $2.58 |
| Operating Cash Flow (TTM) | $164.14M | $616.20M |
| Levered Free Cash Flow (TTM) | $116.79M | $291.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.90% |
| Last 12-Month Dividend | N/A | $1.35 |
Valuation & Enterprise Metrics Analysis: Repligen vs AptarGroup
| Metric | RGEN | ATR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 511.11 | 24.30 |
| Forward P/E | 65.76 | 23.73 |
| PEG Ratio | 65.76 | 23.73 |
| Price to Sales (TTM) | 9.76 | 2.57 |
| Price to Book (MRQ) | 3.31 | 3.43 |
| Market Capitalization | ||
| Market Capitalization | $6.58B | $9.27B |
| Enterprise Value | $6.67B | $10.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.89 | 2.81 |
| Enterprise to EBITDA | 55.78 | 12.70 |
| Risk & Other Metrics | ||
| Beta | 1.05 | 0.57 |
| Book Value per Share (MRQ) | $35.34 | $41.04 |
Financial Statements Comparison: Repligen vs AptarGroup
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RGEN | ATR |
|---|---|---|
| Revenue/Sales | $169.17M | $887.31M |
| Cost of Goods Sold | $78.42M | $550.89M |
| Gross Profit | $90.76M | $336.41M |
| Research & Development | $12.92M | N/A |
| Operating Income (EBIT) | $6.58M | $115.49M |
| EBITDA | $29.07M | $186.15M |
| Pre-Tax Income | $7.94M | $106.02M |
| Income Tax | $2.11M | $27.35M |
| Net Income (Profit) | $5.83M | $78.66M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RGEN | ATR |
|---|---|---|
| Cash & Equivalents | $697.23M | $125.84M |
| Total Current Assets | $1.03B | $1.51B |
| Total Current Liabilities | $152.00M | $1.21B |
| Long-Term Debt | $668.54M | $612.02M |
| Total Shareholders Equity | $1.99B | $2.55B |
| Retained Earnings | $413.18M | $2.42B |
| Property, Plant & Equipment | $265.24M | $66.57M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RGEN | ATR |
|---|---|---|
| Operating Cash Flow | $14.16M | $100.50M |
| Capital Expenditures | $-3.52M | $79,000 |
| Free Cash Flow | $10.58M | $23.41M |
| Debt Repayment | N/A | $-4.55M |
| Common Stock Repurchase | N/A | $-80.00M |
Short Interest & Institutional Ownership Analysis
| Metric | RGEN | ATR |
|---|---|---|
| Shares Short | 3.40M | 901,388 |
| Short Ratio | 4.65 | 2.53 |
| Short % of Float | 0.08% | 0.02% |
| Average Daily Volume (10 Day) | 1,189,571 | 520,779 |
| Average Daily Volume (90 Day) | 868,660 | 407,540 |
| Shares Outstanding | 56.09M | 66.50M |
| Float Shares | 52.57M | 65.33M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 1.05% | 0.96% |
Dividend Analysis & Yield Comparison: Repligen vs AptarGroup
| Metric | RGEN | ATR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.35 |
| Last 12-Month Dividend Yield | N/A | 0.90% |
| 3-Year Avg Annual Dividend | N/A | $1.50 |
| 3-Year Avg Dividend Yield | N/A | 0.32% |
| 3-Year Total Dividends | N/A | $4.51 |
| Ex-Dividend Date | N/A | Feb 05, 2025 |